Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 47:2074-2085, doi:10.1016/j.jacc.2005.12.064 (Published online 21 April 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Online Videos
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aiba, T.
Right arrow Articles by Sunagawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aiba, T.
Right arrow Articles by Sunagawa, K.

Cellular Basis for Trigger and Maintenance of Ventricular Fibrillation in the Brugada Syndrome Model

High-Resolution Optical Mapping Study

Takeshi Aiba, MD, PhD*, Wataru Shimizu, MD, PhD{dagger},*, Ichiro Hidaka, MS*, Kazunori Uemura, MD*, Takashi Noda, MD, PhD*, Can Zheng, PhD*, Atsunori Kamiya, MD*, Masashi Inagaki, MD*, Masaru Sugimachi, MD, PhD* and Kenji Sunagawa, MD, PhD*

* Department of Cardiovascular Dynamics, Research Institute, National Cardiovascular Center, Suita, Japan
{dagger} Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Japan.


Figure 1
View larger version (27K):

[in a new window]
 
Figure 1 Schematic diagram showing the major components of high-resolution optical mapping of the epicardial (Epi) or endocardial (Endo) surface in an arterially perfused canine right ventricular (RV) wedge preparation. CMOS = complementary metal oxide semiconductor.

 

Figure 2
View larger version (27K):

[in a new window]
 
Figure 2 Representative episodes of polymorphic ventricular tachycardia or ventricular fibrillation (VF) in a canine wedge model of the Brugada syndrome. All arrhythmias were spontaneously developed after the electrocardiogram with coved-type ST-segment elevation. Many of the arrhythmias (numbers 1 to 6) terminated within a few seconds, but the others (numbers 7 to 9) with a shorter cycle length (CL) degenerated into VF, which continued more than 5 s.

 

Figure 3
View larger version (46K):

[in a new window]
 
Figure 3 Representative action potential duration measured at 50% repolarization (APD50) contour map on the right ventricular epicardium (Epi) and endocardium (Endo) in control condition (A and D, respectively), in the ST-segment elevation (Brugada-ECG) without phase 2 re-entrant (P2R) extrasystoles (B and E, respectively), and in the Brugada-ECG just before P2R extrasystoles (C and F, respectively) and representative optical action potentials at each site (a to c). White arrow = initial site of P2R. DR = dispersion of repolarization; GRmax = maximum gradient of repolarization.

 

Figure 4
View larger version (19K):

[in a new window]
 
Figure 4 Scatter plots of the maximum gradient of repolarization (GRmax) in the epicardial (Epi) and endocardial (Endo) surfaces (A) and transmural dispersion of repolarization (DR) (B) in control and the ST-segment elevation (Brugada-ECG) condition with (closed circles) or without (open circles) phase 2 re-entrant (P2R) extrasystoles. Values are mean ± SD. *p < 0.05 versus control condition; {dagger}p < 0.05 versus Brugada-ECG condition without P2R-extrasystole by analysis of variance with Scheffe’s test.

 

Figure 5
View larger version (53K):

[in a new window]
 
Figure 5 Snapshots of a color optical isopotential movie on the epicardial surface for the continuous two beats with (Beat 2) and without (Beat 1) a phase 2 re-entrant extrasystole (P2R-extrasystole) in the Brugada-ECG condition (A). Depolarization map of a P2R-extrasystole (B) and optical action potentials at each site (a to f) and transmural electrocardiogram (ECG) (C). Please see the for accompanying video.

 

Figure 6
View larger version (64K):

[in a new window]
 
Figure 6 Representative repolarization and depolarization maps on the epicardial surface in the ST-segment elevation (Brugada-ECG) condition just before non-sustained polymorphic ventricular tachycardia (VT) (A, B), snapshots of phase movie during polymorphic VT originated from the epicardial phase 2 re-entry (C), and optical action potentials at each site (a to f) together with a transmural electrocardiogram (ECG) (D). Open circles = singularity points. APD50 = action potential duration at 50% repolarization. Please see the for accompanying video.

 

Figure 7
View larger version (84K):

[in a new window]
 
Figure 7 Representative repolarization and depolarization maps on the epicardial surface in the ST-segment elevation (Brugada-ECG) condition just before ventricular fibrillation (VF) (A, B), snapshots of phase movie during VF originated from the epicardial phase 2 re-entry (C), and optical action potentials at each site (a to f) together with a transmural electrocardiogram (ECG) (D). Open circles = singularity points. APD50 = action potential duration at 50% repolarization. Please see the for accompanying videos.

 

Figure 8
View larger version (42K):

[in a new window]
 
Figure 8 Representative epicardial depolarization maps paced from the epicardium by S1-S2 method in the control and ST-segment elevation (Brugada-ECG) condition with polymorphic ventricular tachycardia (PVT) or ventricular fibrillation (VF) (A), and longitudinal (L) and transverse (T) conduction velocity ({theta}) restitution curves in each condition (B). Values are mean ± SEM.

 

Figure 9
View larger version (50K):

[in a new window]
 
Figure 9 Representative epicardial repolarization maps paced from the epicardium by S1-S2 method and plot of the restitution of action potential duration at each site (a to e) and superimposed optical action potentials at site b in control condition (A), and the Brugada-ECG condition with polymorphic ventricular tachycardia (PVT) (B) or ventricular fibrillation (VF) (C). APD50 = action potential duration at 50% repolarization; DI = diastolic interval.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement